We are live on ! Find out more
AUXL

AUXILIUM PHARAMCEUTICALS INC
AUXL

Delisted

AUXL was delisted on the 29th of January, 2015.

Back to rankings

1 hedge funds and large institutions have $3.38M invested in AUXILIUM PHARAMCEUTICALS INC in 2015 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 156 closing their positions.

New
Increased
Maintained
Reduced
Closed

99% less funds holding

Funds holding: 158 → 1 (-157)

100% less capital invested

Capital invested by funds: $2.19B → $3.38M (-$2.19B)

100% less funds holding in top 10

Funds holding in top 10: 8 → 0 (-8)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 156

Holders
1
Holders Change
-157
Holders Change %
-99.37%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
-8
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
156
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$216M
2
PAI
Palo Alto Investors
California
-$169M
3
PCM
Pentwater Capital Management
Florida
-$130M
4
Vanguard Group
Vanguard Group
Pennsylvania
-$107M
5
AQR Capital Management
AQR Capital Management
Connecticut
-$89.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
Northern Trust
26
Northern Trust
Illinois
– -$20.1M -585,995 Closed
GCL
27
Glazer Capital LLC
New York
– -$19.9M -579,027 Closed
Goldman Sachs
28
Goldman Sachs
New York
– -$19.7M -571,610 Closed
UOC
29
UBS O'Connor
Illinois
– -$18.5M -537,388 Closed
OAC
30
OMERS Administration Corp
Ontario, Canada
– -$18.1M -526,700 Closed
PI
31
Putnam Investments
Massachusetts
– -$17.9M -521,900 Closed
Susquehanna International Group
32
Susquehanna International Group
Pennsylvania
– -$17M -493,405 Closed
GCIA
33
Gabelli & Co Investment Advisers
New York
– -$16.5M -479,644 Closed
GP
34
GLG Partners
United Kingdom
– -$16.4M -476,121 Closed
Renaissance Technologies
35
Renaissance Technologies
New York
– -$16.1M -468,040 Closed
AL
36
Airain Ltd
Guernsey
– -$15.2M -441,239 Closed
STMM
37
South Texas Money Management
Texas
– -$14M -406,811 Closed
CS
38
Credit Suisse
Switzerland
– -$12.4M -359,972 Closed
AGC
39
Angelo Gordon & Co
New York
– -$11.2M -325,000 Closed
SCM
40
Stevens Capital Management
Pennsylvania
– -$10.4M -303,256 Closed
HMC
41
Harvard Management Company
Massachusetts
– -$10.3M -300,000 Closed
Citigroup
42
Citigroup
New York
– -$9.88M -287,344 Closed
Geode Capital Management
43
Geode Capital Management
Massachusetts
– -$9.42M -274,080 Closed
Bank of New York Mellon
44
Bank of New York Mellon
New York
– -$9.12M -265,268 Closed
TCIM
45
TIAA CREF Investment Management
New York
– -$8.77M -255,078 Closed
Norges Bank
46
Norges Bank
Norway
– -$7.44M -216,279 Closed
AC
47
Amici Capital
New York
– -$6.88M -200,230 Closed
CI
48
Cowen Inc
New York
– -$6.63M -192,741 Closed
BCM
49
BlueCrest Capital Management
Jersey
– -$6.16M -179,062 Closed
Wellington Management Group
50
Wellington Management Group
Massachusetts
– -$6.1M -177,293 Closed
1
2
3 4 5

AUXL Hedge Fund Activity: Q1 2015 in Review

1 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in AUXILIUM PHARAMCEUTICALS INC (AUXL) for Q1 2015, worth a combined $3.38M — down 100% from $2.19B a quarter earlier.

Sellers outnumbered buyers: 156 funds closed out of AUXL and 0 opened new positions — a net loss of 156 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Deerfield Management, exiting entirely with an estimated $216M sold.

  • 1 institutional investor held AUXILIUM PHARAMCEUTICALS INC (AUXL) as of Q1 2015, down from 158 in Q4 2014.
  • Funds reported $3.38M of AUXILIUM PHARAMCEUTICALS INC stock for Q1 2015, down 100% quarter-over-quarter.
  • 0 funds opened new AUXILIUM PHARAMCEUTICALS INC positions in Q1 2015 and 156 closed out, a net change of -156 holders.
  • The largest AUXILIUM PHARAMCEUTICALS INC seller in Q1 2015 was Deerfield Management, an estimated $216M sold.

Based on aggregated 13F filings for Q1 2015.